United States · FDA National Drug Code directory
ciprofloxacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43063-869_36c1922f-56d3-9a55-e063-6294a90a5571
- Product NDC
- 43063-869
- Form
- TABLET
- Composition / generic term
- ciprofloxacin
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20040910
- Source listing expiry
- 20261231
Source-listed ingredients
- CIPROFLOXACIN HYDROCHLORIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET in 1 BOTTLE, PLASTIC (43063-869-06) · 43063-869-06
- 8 TABLET in 1 BOTTLE, PLASTIC (43063-869-08) · 43063-869-08
- 10 TABLET in 1 BOTTLE, PLASTIC (43063-869-10) · 43063-869-10
- 20 TABLET in 1 BOTTLE, PLASTIC (43063-869-20) · 43063-869-20
- 30 TABLET in 1 BOTTLE, PLASTIC (43063-869-30) · 43063-869-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →